Found 7295 matches for
The CTP in Advanced Bioscience of Viral Products (ABViP) is a 4-year, comprehensive, multidisciplinary training programme designed and led by gene and cell therapy company Oxford Biomedica in collaboration with the University of Oxford and University College London. The programme aims to deliver the next generation of bioscience leaders to advance research on the underpinning bioscience of viral products for future gene therapies and vaccines.
Dr Simon Warner is Head of Licensing & Ventures - Life Sciences at Oxford University Innovation (OUI). Simon has over twenty-five years’ experience in commercial Biotechnology in various roles, raising venture capital, securing strategic partners and philanthropic funding sources. We talk to Simon about his career to date, his role at OUI, and his passion for seeing innovative ideas and inventions make it to real life.
The University of Oxford has entered into a strategic collaboration with Janssen Immunology, to create a detailed cellular atlas across multiple immune-mediated inflammatory disorders (IMIDs).
Read the latest publications from Oxford-BMS Fellows